featured
news articles

Total number of categories

Total number of articles

Market/Novel Tech

Ophthalmic biopharmaceutical company raises $7.5M for the development of new treatments for sight-threatening disorders

Ocugen Inc., an ophthalmic biopharmaceutical company based in Pennsylvania, USA, has announced the close of a $7.5M venture capital funding to support the development of new therapeutics for a range of sight-threatening diseases. The company has a series of novel treatment approaches for ophthalmic disorders which include ocular graft versus host disease, retinitis pigmentosa, geographic […]

Read full story
Featured

Phase III results of experimental gene therapy treatment for RPE-65 mediated retinal dystrophy report statistical and clinically meaningful benefit

Findings from a clinical research study published in the Lancet (Jul 13, 2017) show that patients with RPE-65 mediated retinopathy had a “statistically significant and clinically meaningful difference” in the primary trial endpoint of “multi-luminance mobility testing” (MLMT). The endpoint itself represents an innovation built into the study and approved by regulators as a meaningful […]

Read full story
Research

UK study indicates that type 2 diabetics with sleep apnoea appear to carry an increased risk of sight-threatening retinopathy

A UK study, published in the American Journal of Respiratory Critical Care Medicine (Jun 8, 2017), indicates that patients with type 2 diabetes and obstructive sleep apnoea (OSA) are at a significantly increased risk of sight-threatening diabetic retinopathy. According to the authors of the non-interventional study, the research represents the first longitudinal examination of the […]

Read full story
Introduction

July 17th, 2017: “EURETINA-Brief”© Issue No. 157

by Dr. Gearóid Tuohy   Dear EURETINA Members,   A very warm welcome to the July 17th, 2017 edition of EURETINA’s web-based digital magazine, “EURETINA Brief”. EURETINA are delighted to continue our delivery of up-to-date summary briefs on a range of topics of interest to retinal clinicians, specialists and researchers across Europe. This resource is […]

Read full story
Featured

Findings from an international genomics consortium almost double the number of associated genetic loci and variants for AMD

Research conducted by the International AMD Genomics Consortium (IAMDGC) has recently reported an almost doubling in the number of genetic risk loci associated with age-related macular degeneration (AMD). In a significant publication in the journal Nature Genetics, the research group has reported on an analysis of >12 million gene variants, “including 163,714 directly genotyped, mostly […]

Read full story
Featured

Findings from an international genomics consortium almost double the number of associated genetic loci and variants for AMD

Research conducted by the International AMD Genomics Consortium (IAMDGC) has recently reported an almost doubling in the number of genetic risk loci associated with age-related macular degeneration (AMD). In a significant publication in the journal Nature Genetics, the research group has reported on an analysis of >12 million gene variants, “including 163,714 directly genotyped, mostly […]

Read full story

Latest News

Book Review